MetLife (MET)
(Delayed Data from NYSE)
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$78.43 USD
+0.01 (0.01%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $78.42 -0.01 (-0.01%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum C VGM
Zacks News
Will MetLife's Growth Be Affected by Pending SIFI Status?
by Zacks Equity Research
On Jan 3, 2017, we issued an updated research report on MetLife Inc (MET).
4 Insurance Stocks with Bright Prospects in 2017
by Zacks Equity Research
The long suffering for insurers seems to be finally over as the much-awaited interest rate hike has materialized after seven years.
New Stock Research Reports for June 23, 2016
by Sheraz Mian
Today's must-read reports are for IBM (IBM), General Motors Company (GM) and MetLife, Inc. (MET).
Stock Market News for March 31, 2016
by Zacks Equity Research
Here's Why Old Republic (ORI) is a Buy
by Jeremy Mullin
Growth & Income Stock Strategist, Todd Bunton, CFA, highlights Old Republic International (ORI) on November 4, 2015.